https://www.selleckchem.com/products/pbit.html
There was no statistically significant difference in secondary outcomes except for lower cholecystectomy rates in RA patients. With a high inflammatory state, it was hypothesized that RA would be associated with worse outcomes after ERCP. Yet, the primary outcomes of mortality and hospital cost were found to be lower than controls, with no difference in secondary outcomes. We posit that immunosuppressants used to treat RA provides a protective effect to overall complications with ERCP. With a high inflammatory state, it was hypothesized th
Like
Comment
Share
